help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on July 19, 2005
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-0907
A more recent version of this article appeared on October 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
90/10/5536    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stubbs, S. A.
Right arrow Articles by Franks, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stubbs, S. A.
Right arrow Articles by Franks, S.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH

Submitted on April 26, 2005
Accepted on July 8, 2005

Anti-Müllerian Hormone (AMH) protein expression is reduced during the initial stages of follicle development in human polycystic ovaries

Sharron A. Stubbs, Kate Hardy*, Patricia Da Silva-Buttkus, Jaroslav Stark, Lisa J. Webber, Adrienne M. Flanagan, Axel P.N. Themmen, Jenny A. Visser, Nigel P. Groome, and Stephen Franks

Institute of Reproductive and Developmental Biology, Wolfson and Weston Research Centre for Family Health, Imperial College London, Hammersmith Hospital, London, W12 0NN, UK; Department of Mathematics, Imperial College London, London SW7 2AZ UK; Histopathology Department, Division of Investigative Sciences, Imperial College London, St. Mary's Hospital, London W2 1PG; Department of Internal Medicine, Erasmus MC, 3015 GD, Rotterdam, The Netherlands; School of Biological and Molecular Sciences, Oxford Brookes University, Headington Oxford, UK

* To whom correspondence should be addressed. E-mail: k.hardy{at}imperial.ac.uk.

Context: Polycystic ovary syndrome (PCOS), the commonest cause of anovulatory infertility, is characterized by disordered folliculogenesis, notably increased progression from the primordial to the primary stages. This ovarian phenotype is similar to that observed in mice lacking anti-Müllerian hormone (AMH).

Objective: To investigate whether AMH is involved in accelerating the transition of follicles from primordial to primary stages in polycystic ovaries.

Design: Comparison of AMH expression in archive tissue from normal and polycystic ovaries.

Setting: Laboratory-based study.

Patients: 7 normo-ovulatory women and 16 women with polycystic ovaries (5 of whom were anovulatory), classified by ovarian histology and with reference to menstrual cycle history and ultrasound.

Main outcome measure: Presence and intensity of AMH expression in 1403 follicles.

Results: AMH was observed from the primordial stage onwards. AMH immunostaining was observed in significantly fewer primordial (P = 0.007) and transitional follicles (P = 0.001) in ovaries from anovulatory women with PCO compared with women with regular cycles and either normal or polycystic ovaries. AMH-negative follicles had fewer pre-granulosa cells in the largest cross-section of the follicle at both the primordial (median 4 and 6 for AMH-negative and positive follicles respectively, p = <0.0001) and transitional stages (median 6 and 9, p = <0.0007) in normal tissue, and fewer at the transitional stage (median 7 and 11, p = <0.0001) in tissue from anovulatory women with polycystic ovaries. This suggests that AMH expression is associated with granulosa cell mitosis.

Conclusions: These findings indicate a relative deficiency of AMH in primordial and transitional follicles in ovaries from anovulatory women with polycystic ovaries. This may contribute to disordered early follicle development in PCOS.


Key words: Ovary • PCOS • Müllerian inhibiting substance • Follicle • Folliculogenesis • Immunohistochemistry




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
D. M. Robertson, G. E. Hale, D. Jolley, I. S. Fraser, C. L. Hughes, and H. G. Burger
Interrelationships between Ovarian and Pituitary Hormones in Ovulatory Menstrual Cycles across Reproductive Age
J. Clin. Endocrinol. Metab., January 1, 2009; 94(1): 138 - 144.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
P. Da Silva-Buttkus, G. S. Jayasooriya, J. M. Mora, M. Mobberley, T. A. Ryder, M. Baithun, J. Stark, S. Franks, and K. Hardy
Effect of cell shape and packing density on granulosa cell proliferation and formation of multiple layers during early follicle development in the ovary
J. Cell Sci., December 1, 2008; 121(23): 3890 - 3900.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
A I Qureshi, S S Nussey, G Bano, P Musonda, S A Whitehead, and H D Mason
Testosterone selectively increases primary follicles in ovarian cortex grafted onto embryonic chick membranes: relevance to polycystic ovaries
Reproduction, August 1, 2008; 136(2): 187 - 194.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
S. Franks, J. Stark, and K. Hardy
Follicle dynamics and anovulation in polycystic ovary syndrome
Hum. Reprod. Update, May 22, 2008; (2008) dmn015v1.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
P.A Johnson, T.R Kent, M.E Urick, and J.R Giles
Expression and Regulation of Anti-Mullerian Hormone in an Oviparous Species, the Hen
Biol Reprod, January 1, 2008; 78(1): 13 - 19.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. A. Stubbs, J. Stark, S. M. Dilworth, S. Franks, and K. Hardy
Abnormal Preantral Folliculogenesis in Polycystic Ovaries Is Associated with Increased Granulosa Cell Division
J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4418 - 4426.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. S. Wachs, M. S. Coffler, P. J. Malcom, and R. J. Chang
Serum Anti-Mullerian Hormone Concentrations Are Not Altered by Acute Administration of Follicle Stimulating Hormone in Polycystic Ovary Syndrome and Normal Women
J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1871 - 1874.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. J. Webber, S. A. Stubbs, J. Stark, R. A. Margara, G. H. Trew, S. A. Lavery, K. Hardy, and S. Franks
Prolonged Survival in Culture of Preantral Follicles from Polycystic Ovaries
J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1975 - 1978.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. H. Thomas, E. E. Telfer, and H. M. Fraser
Expression of Anti-Mullerian Hormone Protein during Early Follicular Development in the Primate Ovary in Vivo Is Influenced by Suppression of Gonadotropin Secretion and Inhibition of Vascular Endothelial Growth Factor
Endocrinology, May 1, 2007; 148(5): 2273 - 2281.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. L. Rosenfield
Identifying Children at Risk for Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 787 - 796.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Rice, K. Ojha, S. Whitehead, and H. Mason
Stage-Specific Expression of Androgen Receptor, Follicle-Stimulating Hormone Receptor, and Anti-Mullerian Hormone Type II Receptor in Single, Isolated, Human Preantral Follicles: Relevance to Polycystic Ovaries
J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 1034 - 1040.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
G. Meduri, N. Massin, J. Guibourdenche, A. Bachelot, O. Fiori, F. Kuttenn, M. Misrahi, and P. Touraine
Serum anti-Mullerian hormone expression in women with premature ovarian failure
Hum. Reprod., January 1, 2007; 22(1): 117 - 123.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
D. Modi, D. Bhartiya, and C. Puri
Developmental expression and cellular distribution of Mullerian inhibiting substance in the primate ovary.
Reproduction, September 1, 2006; 132(3): 443 - 453.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Sir-Petermann, E. Codner, M. Maliqueo, B. Echiburu, C. Hitschfeld, N. Crisosto, F. Perez-Bravo, S. E. Recabarren, and F. Cassorla
Increased Anti-Mullerian Hormone Serum Concentrations in Prepubertal Daughters of Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 3105 - 3109.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society